SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £203.60m
BVT Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead Vt Share Chart

Correction: Interim Management Statement

18 Aug 2014 09:42

RNS Number : 3747P
Baronsmead VCT 2 PLC
18 August 2014
Β 

ο»Ώ

The Baronsmead VCT 2 plc Interim Management Statement announcement released at 16:22 on 15 August 2014 incorrectly stated the interim dividend paid on 7 March 2014 which should have read 8p per share.

Β 

The correction is included in the full text of the announcement below.

Β 

Β 

Β 

BaronsmeadΒ VCTΒ 2 plc

Β 

InterimΒ ManagementΒ Statement

Β 

For the 3 month period from 1 April 2014 to 30 June 2014.

Β 

Headlines

Β 

Β· Β£1.8 million realised from the sale of investments in four quoted companies

Β 

Β· Β£0.4 million invested in 1 new and 3 follow-on investments

Β 

PerformanceΒ Summary

Β 

Β 

Capital return

As at

30 June 2014

As at

31 March 2014

Β 

Movement

Total net assets

Β£86.63m

Β£86.50m

Net asset value per share

102.56p

102.19p

0.4%

Share price

97.75p

95.75p

2.1%

Discount to NAV

(4.7%)

(6.3%)

Total Return

3 month (%)

1 year (%)

5 year (%)

10 year (%)

Since launch (%)

Net asset value total return (1)

0.4

15.5

75.0

123.9

217.1

Β 

Key:

(1)Β NAV total return = NAV + reinvested dividends; Source: ISISΒ VC LLP

Β 

These total returns are stated before the inclusion of VCT tax reliefsΒ whichΒ are designed toΒ mitigateΒ the higher risksΒ and costsΒ associated with investing in smaller companiesΒ and the constraints of the VCT legislation. The tax reliefsΒ given at the time ofΒ subscriptionΒ have varied between 20% and 40%, so any adjusted performance measure including this relief will vary depending on the date of subscription. There is also the additional ongoing benefit of receiving VCT dividends tax free.

Β 

Β Investment PerformanceΒ Β 

Β 

In the three months to 30 June 2014, Baronsmead VCT 2's net asset value per share increased by 0.4%. Over the quarter, the unquoted portfolio valuation increased by 1.9%, the quoted portfolio increased by 1.3% and Wood Street Microcap Fund decreased by 4.4%.

Β 

The Company's net assets as at 30 June 2014 were Β£86.6 million. This figure takes into account the valuation of the Company's investments as at 30 June 2014.

Β Top Ten InvestmentsΒ 

Β 

Position atΒ 

30 June 2014

Position atΒ 

31 March 2014

Β 

Β Company

Percentage ofΒ NAVΒ 

as at 30 June 2014

1

1

Nexus Vehicle Holdings Limited

6.1

2

3

Staffline Group plc

3.5

3

2

Netcall plc

3.4

4

4

IDOX plc

3.2

5

5

Crew Clothing Holdings Limited

2.8

6

7

Valldata Group Limited

2.1

7

14

Accumuli plc

2.0

8

6

Vectura Group plc

1.8

9

8

Independent Community Care Management Limited

1.8

10

12

Create Health Limited

1.8

Total

28.5

Β 

Analysis of Total Assets

Percentage of total assets at

30 June 2014

Percentage of

total assets at

31 March 2014

Unquoted investments

31

31

AIM, listed, ISDX & collective investment vehicle

46

48

Listed interest bearing securities

12

-

Net current assets

11

21

Total liquid assets

23

21

Total assets

100

100

Β 

Β 

Analysis of Investment Portfolio by Sector

(excluding cash and interest bearing securities)

Β 

Percentage of

Total investments at

30 June 2014

Percentage of

Β total investments atΒ 

31 March 2014

Business Services

47

46

Consumer Markets

11

12

Healthcare & Education

14

15

Technology, Media & Telecommunications

28

27

Total

100

100

Β 

Β 

Β 

Investment Activity

Β 

In the three months to 30 June 2014, Baronsmead VCT 2 invested approximately Β£0.4 million in 1 new and 3 follow on investments as set out in the table below.

Β 

Investments made

Date

Cost (Β£'000)

One Media iP Group plc*

Apr 2014

57

Synety Group plc

Apr 2014

113

Happy Days Consultancy Limited*

May 2014

180

Nexus Vehicle Holdings Limited*

May 2014

8

Total investments

358

*Follow on investmentsRealisations

Β 

In the three months to 30 June 2014, Baronsmead VCT 2 realised total proceeds of Β£1.8 million from the sale of four quoted investments. Details are set out in the table below.

Β 

Β 

Realisations

Company

Date

Cost

(Β£'000)

Proceeds

(Β£'000)

Multiple

Β 

Anpario plc

Apr/Jun 2014

69

284

4.1

Sinclair IS Pharma plc

May 2014

524

546

1.0

Murgitroyd Group plc

May/Jun 2014

130

707

5.4

Tristel plc

Jun 2014

217

281

1.3

Total realisations

940

1,818

Β 

Β 

Dividend

Β 

Following an exceptional period of divestments, an interim dividend of 8p per share was paid on 7 March 2014. In the absence of unforeseen circumstances, it is anticipated that a second interim dividend will be paid in September 2014

Β 

Net Asset Value as at 31 July 2014

Β 

The net asset value as at 31 July 2014 was 102.82p per share.

Β 

Investment objective

Β 

Baronsmead VCT 2 is a tax efficient listed company which aims to achieve long-term investment returns for private investors, including tax free dividends.

Β 

Β 

Events after the period end

Β 

Other than the events described above, the Board is not aware of any significant events or transactions which have occurred between 30 June 2014 and the date of publication of this statement which would have a material impact on the financial position of the Company.

Β 

Β 

FurtherΒ informationΒ 

Β 

Further information regarding the Company, including net asset values published since the end of the period and quarterly factsheets, can be found at the Company's websiteΒ www.baronsmeadvct2.co.uk

Β 

Β 

Contact

Β 

For further information please contact the Company's Investment Manager, ISIS VC LLP as follows:

Email: baronsmeadvcts@isisep.com

Telephone: 020 7506 5717

Facsimile: 020 7506 5718

Post: 100 Wood Street, London, EC2V 7AN

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSPPMPTMBJBMMI
Date   Source Headline
4th Jun 20263:15 pmRNSNet Asset Value(s)
3rd Jun 202610:15 amRNSNewsletter for the period June 2025 to March 2026
1st Jun 202611:28 amRNSTotal Voting Rights
18th May 20263:45 pmRNSAdmission of Further Securities to Trading
14th May 20262:33 pmRNSDirector/PDMR Shareholding
14th May 20262:15 pmRNSAllotment of Shares and Closure of Offer
11th May 20267:00 amRNSNet Asset Value(s)
5th May 20263:15 pmRNSNet Asset Value(s)
1st May 202611:42 amRNSTotal Voting Rights
8th Apr 202610:15 amRNSAdmission of Further Securities to Trading
1st Apr 202611:48 amRNSTotal Voting Rights
31st Mar 20265:38 pmRNSTransaction in Own Shares
24th Mar 20262:20 pmRNSReplacement - Extension to Application Deadline
24th Mar 202612:20 pmRNSApplication Deadline Extension - Fourth Allotment
20th Mar 20267:00 amRNSResult of AGM
5th Mar 20263:30 pmRNSNet Asset Value(s)
2nd Mar 202611:37 amRNSTotal Voting Rights
26th Feb 202612:15 pmRNSAdmission of Further Securities to Trading
20th Feb 202611:02 amRNSDirector/PDMR Shareholding
19th Feb 20264:31 pmRNSAllotment of Shares and Total Voting Rights
16th Feb 20265:15 pmRNSTransaction in Own Shares
10th Feb 20267:00 amRNSOver-Allotment Facility and Offer Update
5th Feb 20264:15 pmRNSNet Asset Value(s)
2nd Feb 20264:45 pmRNSNet Asset Value(s)
2nd Feb 202610:41 amRNSTotal Voting Rights
29th Jan 20263:35 pmRNSAdmission of Further Securities to Trading
22nd Jan 20263:40 pmRNSAllotment of Shares and Total Voting Rights
12th Jan 202611:35 amRNSPublication of a Supplementary Prospectus
23rd Dec 20257:00 amRNSAnnual Financial Report
23rd Dec 20257:00 amRNSAnnual Financial Report
11th Dec 20257:00 amRNSOffer Update:Close of Early Subscription Incentive
4th Dec 20253:45 pmRNSNet Asset Value(s)
1st Dec 202510:45 amRNSTotal Voting Rights
20th Nov 20251:28 pmRNSDirector/PDMR Shareholding
20th Nov 202512:00 pmRNSAllotment of Shares and Total Voting Rights
6th Nov 20254:00 pmRNSNet Asset Value(s)
29th Oct 20259:45 amRNSNet Asset Value(s)
13th Oct 20252:00 pmRNSPublication of a Prospectus/Offer for Subscription
1st Oct 20257:00 amRNSTotal Voting Rights
29th Sep 20255:53 pmRNSTransaction in Own Shares
24th Sep 20259:50 amRNSQuarterly Factsheet June 2025 & Newsletter H2 2025
24th Sep 20258:45 amRNSUpdate on Offer for Subscription
23rd Sep 20252:51 pmRNSQuarterly Factsheet June 2025 & Newsletter H2 2025
11th Sep 20255:08 pmRNSDirector/PDMR Shareholding
9th Sep 20255:59 pmRNSTransaction in Own Shares
4th Sep 20253:15 pmRNSNet Asset Value(s)
4th Sep 20258:15 amRNSIntention to Fundraise
6th Aug 20254:15 pmRNSNet Asset Value(s)
31st Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 202510:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.